We started clinical application of using stem cell transplantation to treat diabetes since our department’s clinical trial registration was approved by the WHO in April, 2010. (Registration number of stem cell transplantation to treat type 1 diabetes: ChiCTR-TNC-10000986; registration number of stem cell transplantation to treat type 2 diabetes: ChiCTR-ONC-10000985).
Till the end of 2016, our department treated more than 508 patients of type 2 diabetes, and the treatment is effective to over 93% of patients, and 60% of patients have a better blood glucose control with half dose of the insulin than before. After the first course of treatment, 30% of patients can stop using insulin and oral hypoglycemic drugs. The treatment is effective to improve the blurred vision caused by diabetic retinopathy and diabetic peripheral neuropathy (DPN), and it also treat the symptoms such as numb, coldness, needle punching pain and feeling of electrical shock in the limbs.
Our department has treated more than 81 patients with type 1 diabetes, and the patients have steadier blood sugar concentration and use less insulin than before, which reduce the chances of having acute complications such as diabetic ketoacidosis and hypoglycemia, and improved patient’s living quality.
After the first month of treatment, the blood sugar concentration may be unsteady, but normally it can be stabilized within 3 months. According to our follow-up observation data, if the patient has better improvements on blood glucose controlling and complications after the first course of treatment, then patient is recommended to try the second course of treatment to get a continuous and steady improvement 6 months after the first course of the treatment.
Now our treating technique and methods are more mature and varied than before, and the curative effect is also much better. Nowadays, more and more patients including foreigners are coming for treatment.